BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6426474)

  • 1. Low sulfated glycosaminoglycans are excreted in patients with the Lowe syndrome.
    Kieras FJ; Houck GE; French JH; Wisniewski K
    Biochem Med; 1984 Apr; 31(2):201-10. PubMed ID: 6426474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of a large amount of bound sialic acid and of under sulfated chondroitin sulfate A by patients with the Lowe syndrome.
    Akasaki M; Fukui S; Sakano T; Tanaka T; Usui T; Yamashina I
    Clin Chim Acta; 1978 Oct; 89(1):119-25. PubMed ID: 152172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary acid glycosaminoglycans in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):225-34. PubMed ID: 734647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
    Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
    Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-sulfated chondroitin sulfate in human blood and urine.
    Hata RI; Ohkawa SI; Nagai Y
    Biochim Biophys Acta; 1978 Oct; 543(2):156-66. PubMed ID: 728458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural, neurological, and glycosaminoglycan abnormalities in lowe's syndrome.
    Wisniewski KE; Kieras FJ; French JH; Houck GE; Ramos PL
    Ann Neurol; 1984 Jul; 16(1):40-9. PubMed ID: 6087720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC glycosaminoglycan analysis in patients with Graves' disease.
    Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
    Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lowe syndrome--a case study with special reference to urinary acidic mucopolysaccharides and kidney biopsy].
    Nagata T; Sakuma T; Yamaguchi A; Nagai H; Nagasawa S
    Nihon Jinzo Gakkai Shi; 1975 Mar; 17(3):147-59. PubMed ID: 138759
    [No Abstract]   [Full Text] [Related]  

  • 10. Polydispersity of glycosaminoglycans in normal human urine.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 Aug; 131(4):327-37. PubMed ID: 6781104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
    Dietrich CP; Martins JR; Sampaio LO; Nader HB
    Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionation with ethanol of human urinary glycosaminoglycans.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 May; 131(1):23-8. PubMed ID: 6773184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
    Satake S; Ototani N; Isemura M; Yosizawa Z
    Tohoku J Exp Med; 1983 May; 140(1):89-96. PubMed ID: 6408765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues.
    Murata K; Yokoyama Y
    Atherosclerosis; 1989 Jul; 78(1):69-79. PubMed ID: 2502994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, identification, and quantitation of urinary glycosaminoglycans.
    Lee EY; Kim SH; Whang SK; Hwang KY; Yang JO; Hong SY
    Am J Nephrol; 2003; 23(3):152-7. PubMed ID: 12646785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and secretion of glycosaminoglycans in cultured retinal pigment epithelium.
    Stramm LE
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):618-27. PubMed ID: 3104227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired synthesis of intracellular heparan sulfate in skin fibroblasts of Lowe's syndrome.
    Yokoi T; Taniguchi N; Ikawa K
    J Lab Clin Med; 1982 Sep; 100(3):461-8. PubMed ID: 6213727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
    Murata K; Takeda M
    Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.